• Articles of Interest

  FDA Accelerated Approval for Padcev – (Enfortumab-vedotin)

  Posted by Jack R on January 14, 2020 at 6:39 am

  Log In to Reply

  Start of Discussion

  0 of 0 replies June 2018

  Now

  News from late December 2019,

  FDA Approves Padcev (enfortumab vedotin-ejfv) for Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer.

  Another option to look into for those of us who are not good surgical candidates. I could not join the study because of other medical problems, but it was one of two that looked promising.
  Info at

  https://www.drugs.com/newdrugs/fda-approves-padcev-enfortumab-vedotin-ejfv-locally-advanced-metastatic-urothelial-cancer-most-5125.html

  Best to all,
  Jack

  ---

  6/2015 HG Papillary & CIS
  3 Years and 30 BCG/BCG+Inf
  Tis CIS comes back.
  BC clear as of 5/17 !
  RCC found in my one & only kidney 10/17
  Begin Chemo; Cisplatin and Gemzar
  8/18 begin Chemo# 3
  Begin year 4 with cis
  2/19 Chemo #4
  9/19 NED again :)
  1/2020 CIS is back
  Tried Keytruda, stopped by side effects
  Workin on a new plan for 2021

  Jack R replied 4 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply